000 01359 a2200361 4500
005 20250517114035.0
264 0 _c20161230
008 201612s 0 0 eng d
022 _a1536-0229
024 7 _a10.1097/RLU.0000000000001358
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWei, Xiao
245 0 0 _aSuccessful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617.
_h[electronic resource]
260 _bClinical nuclear medicine
_cNov 2016
300 _a894-895 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged, 80 and over
650 0 4 _aDipeptides
_xtherapeutic use
650 0 4 _aHeterocyclic Compounds, 1-Ring
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aLiver Neoplasms
_xdiagnostic imaging
650 0 4 _aLutetium
650 0 4 _aMale
650 0 4 _aProstate-Specific Antigen
650 0 4 _aProstatic Neoplasms, Castration-Resistant
_xdiagnostic imaging
650 0 4 _aRadiopharmaceuticals
_xtherapeutic use
700 1 _aSchlenkhoff, Carl
700 1 _aSopora, Claudia
700 1 _aEssler, Markus
700 1 _aAhmadzadehfar, Hojjat
773 0 _tClinical nuclear medicine
_gvol. 41
_gno. 11
_gp. 894-895
856 4 0 _uhttps://doi.org/10.1097/RLU.0000000000001358
_zAvailable from publisher's website
999 _c26400454
_d26400454